1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Dominari Holdings Acquires DatChat

M&A Deal Summary

Dominari Holdings Acquires DatChat

On March 13, 2018, Dominari Holdings acquired information technology company DatChat

Acquisition Highlights
  • This is Dominari Holdings’ 1st transaction in the Information Technology sector.
  • This is Dominari Holdings’ 2nd transaction in the United States.
  • This is Dominari Holdings’ 1st transaction in New Jersey.

M&A Deal Summary
Date 2018-03-13
Target DatChat
Sector Information Technology
Buyer(s) Dominari Holdings
Deal Type Add-on Acquisition

Target

DatChat

New Brunswick, New Jersey, United States
DatChat, Inc. is a personal privacy platform, focused on encrypted communication, internet security and digital rights management. DatChat was founded in 2014 and is based in New Brunswick, New Jersey.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Dominari Holdings

New York, New York, United States
Category Company
Founded 1967
Sector Information Technology
Employees29
Revenue 18M USD (2024)
DESCRIPTION

Dominari Holdings is a scientific research company that offers a diversified commercialization platform for protected technologies. Dominari Holdings was founded and incorporated in 1967 and is based in New York, New York.

DEAL STATS #
Overall 2 of 4
Sector: Information Technology M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: New Jersey M&A 1 of 1
Country: United States M&A 2 of 4
Year: 2018 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-20 Hoth Therapeutics

United States

Hoth Therapeutics is a development stage biopharmaceutical company focused on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-11 CBM Biopharma

United States

CBM Biopharma LLC is a privately held pharmaceutical company with a team of drug development scientists provides numerous cancer treatment, including acute myeloid leukemia (AML), Acute Lymphoblastic Leukemia (ALL) and pancreatic cancer.

Buy -
Mergr

Solution for

Product

Company

Legal